Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein; protein c; protein s antigen - powder and solvent for solution for infusion - coagulation factor ix (human- rfixfc) 25 iu/ml; coagulation factor ii (human) 14 - 38 iu/ml; coagulation factor vii (human) 9 - 24 iu/ml; coagulation factor x (human) 18 - 30 iu/ml; protein 13 - 41 mg/ml; protein c 13 - 31 iu/ml; protein s antigen 12 - 32 iu/ml - coagulation factor ix, ii, vii and x in combination - treatment of bleeding and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex coagulation factors such as deficiency caused by treatment with vitamin k antagonists or in case of overdose of vitamin k antagonists when rapid correction of the deficiency is required. treatment of bleeding and perioperative prophylaxis in congenital deficiency of any of the vitamin k dependent coagulation factors when purified specific coagulation factor product is not available.

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - powder and solvent for solution for injection - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - powder and solvent for solution for injection - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii - powder and solvent for solution for injection - factor viii 1000 iu/vial - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).this preparation does not contain von willebrand factor in pharmacologically effective quantities and is therefore not indicated in von willebrand’s disease.

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii - powder and solvent for solution for injection - factor viii 500 iu/vial - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)this preparation does not contain von willebrand factor in pharmacologically effective quantities and is therefore not indicated in von willebrand's disease.

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - albumin human; plasma protein fraction - solution for infusion - albumin human 50 g / 1000 ml; plasma protein fraction 96 % - albumin - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 50 mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: • primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndrome. • children with congenital aids and recurrent bacterial infections. immunomodulatory effect: • idiopathic thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. • guillain barre syndrome. • kawasaki disease. allogeneic bone marrow transplantation.• myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - albumin human; plasma protein fraction - solution for infusion - albumin human 200 g / 1000 ml; plasma protein fraction 96 % - albumin - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on the official recommendations

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).

Israel - English - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).